Wall Street expects a year-over-year decline in earnings on lower revenues when Nevro (NVRO) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...

Nevro (NYSE:NVRO – Get Free Report ... shares of the medical equipment provider’s stock valued at $728,000 after acquiring an additional 138,700 shares during the last quarter.

In a report released on February 7, Nathan Treybeck from Wells Fargo maintained a Hold rating on Nevro Corp (NVRO – Research Report), with a price target of $5.85. The company’s shares closed ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nevro Corp (NVRO – Research Report) and Ansell (ANSLF – Research Report). Nevro Corp (NVRO) RBC Capital ...

A multilevel, navigation-based intervention led to more timely initiation of postoperative radiation therapy vs. usual ...